文献速递心血管MR

晚期钆增强影像组学揭示肥厚型心肌病心肌瘢痕异质性的预后价值

Radiomics of Late Gadolinium Enhancement Reveals Prognostic Value of Myocardial Scar Heterogeneity in Hypertrophic Cardiomyopathy.
PubMed 文献 · JACC Cardiovasc Imaging · 2023-06-21

该多中心研究纳入1229例肥厚型心肌病患者,从晚期钆增强图像提取影像组学特征并计算3个主成分影像组学评分,发现其与心脏性猝死风险显著相关,联合ESC或ACC/AHA模型可提升风险预测区分度与重分类,作者称此为概念验证研究、需进一步验证。

要点

  • 心肌晚期钆增强影像组学特征与肥厚型心肌病患者心脏性猝死风险强烈相关。
  • 3个主成分影像组学评分联合ESC或ACC/AHA模型可提升风险预测的c统计量。
  • 瘢痕异质性是主成分影像组学评分的主要成分,且为心脏性猝死风险的显著预测因子。

核心结论

  • 心肌晚期钆增强影像组学与肥厚型心肌病患者心脏性猝死风险强烈相关,并在现有ESC或AHA/ACC风险模型之外提供增量风险分层;作者称该概念验证研究需进一步验证。

研究设计与样本

  • 多中心研究,纳入3个医疗中心的1229例肥厚型心肌病患者(男性62%,年龄52±16岁),从晚期钆增强图像计算左心室心肌影像组学特征,采用主成分分析降维并计算3个主成分影像组学评分,用Cox和logistic回归评估其单独或联合ESC或ACC/AHA模型预测心脏性猝死风险的价值;ACC/AHA风险标志物包括以左心室瘢痕15%为二分阈值的晚期钆增强负荷。

关键影像表现/征象

  • 晚期钆增强瘢痕异质性是主成分影像组学评分的主要成分,且为心脏性猝死风险的显著预测因子(HR 0.07,95%CI 0.01-0.75,P=0.03)。
  • 49±28个月随访期间30例(2.4%)患者发生心脏性猝死事件。

诊断标准与关键数值

  • 主成分影像组学评分预测心脏性猝死风险的c统计量高于ESC模型(0.69 vs 0.57,P=0.02),与ACC/AHA模型无显著差异(0.69 vs 0.67,P=0.75)。
  • 3个主成分影像组学评分联合ESC风险评分后c统计量较单用ESC模型提高(0.73 vs 0.57,P<0.01)。
  • 3个主成分影像组学评分联合ACC/AHA风险评分后c统计量较单用ACC/AHA模型提高(0.76 vs 0.67,P<0.01)。
  • 联合主成分影像组学评分与ESC模型的重分类净改善指数为0.25(95%CI 0.08-0.43,P=0.005)。
  • 联合主成分影像组学评分与ACC/AHA模型的重分类净改善指数为0.05(95%CI -0.07至0.16,P=0.42),未达统计学显著。

临床应用与阅片要点

  • 作者认为心肌晚期钆增强影像组学与肥厚型心肌病患者心脏性猝死风险强烈相关,并可在现有ESC或AHA/ACC风险模型之外提供增量风险分层。
  • 作者称该概念验证研究需进一步验证。

局限性

  • 作者称该研究为概念验证研究,需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Late gadolinium enhancement (LGE) scar burden by cardiac magnetic resonance is a major risk factor for sudden cardiac death (SCD) in hypertrophic cardiomyopathy (HCM). However, there is currently limited data on the incremental prognostic value of integrating myocardial LGE radiomics (ie, shape and texture features) into SCD risk stratification models.

OBJECTIVES: The purpose of this study was to investigate the incremental prognostic value of myocardial LGE radiomics beyond current European Society of Cardiology (ESC) and American College of Cardiology (ACC)/American Heart Association (AHA) models for SCD risk prediction in HCM.

METHODS: A total of 1,229 HCM patients (62% men; age 52 ± 16 years) from 3 medical centers were included. Left ventricular myocardial radiomic features were calculated from LGE images. Principal component analysis was used to reduce the radiomic features and calculate 3 principal radiomics (PrinRads). Cox and logistic regression analyses were then used to evaluate the significance of the extracted PrinRads of LGE images, alone or in combination with ESC or ACC/AHA models, to predict SCD risk. The ACC/AHA risk markers include LGE burden using a dichotomized 15% threshold of LV scar.

RESULTS: SCD events occurred in 30 (2.4%) patients over a follow-up period of 49 ± 28 months. Risk prediction using PrinRads resulted in higher c-statistics than the ESC (0.69 vs 0.57; P = 0.02) and the ACC/AHA (0.69 vs 0.67; P = 0.75) models. Risk predictions were improved by combining the 3 PrinRads with ESC (0.73 vs 0.57; P < 0.01) or ACC/AHA (0.76 vs 0.67; P < 0.01) risk scores. The net reclassification index was improved by combining the PrinRads with ESC (0.25 [95% CI: 0.08-0.43]; P = 0.005) or ACC/AHA (0.05 [95% CI: -0.07 to 0.16]; P = 0.42) models. One PrinRad was a significant predictor of SCD risk (HR: 0.57 [95% CI: 0.39-0.84]; P = 0.01). LGE heterogeneity was a major component of PrinRads and a significant predictor of SCD risk (HR: 0.07 [95% CI: 0.01-0.75]; P = 0.03).

CONCLUSIONS: Myocardial LGE radiomics are strongly associated with SCD risk in HCM and provide incremental risk stratification beyond current ESC or AHA/ACC risk models. Our proof-of-concept study warrants further validation.

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Fahmy, Rowin, Jaafar, et al. Radiomics of Late Gadolinium Enhancement Reveals Prognostic Value of Myocardial Scar Heterogeneity in Hypertrophic Cardiomyopathy. JACC Cardiovasc Imaging. 2023. PMID: 37354155. doi:10.1016/j.jcmg.2023.05.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。